Lv1
40 积分 2022-01-04 加入
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
6天前
已完结
HER2-targeted therapies beyond breast cancer — an update
23天前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
4个月前
已完结
Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
4个月前
已完结
Emerging Treatments for Reactive Cutaneous Capillary Endothelial Proliferation
6个月前
已完结
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: extended follow‐up of the multicenter, single‐arm, phase 2 study
6个月前
已完结
Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines
6个月前
已关闭
In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model
6个月前
已关闭
The Distributional Characteristic and Growing Trend of Pancreatic Cancer in China
6个月前
已完结
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies
6个月前
已完结
皖公网安备34019202002308
